Impact of Low Preoperative Prognostic Immune Nutritional Index on Survival and Postoperative Infectious Complications in Patients With Colorectal Cancer
Annals of Gastroenterological Surgery · 2026-01 · 10 (1) · 154-166
DOI: 10.1002/ags3.70084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Gastroenterological Surgery, online erschienen am 23.08.2025. Verfasst von Shinji Yamashita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reparative Medicine, Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences Mie University Graduate School of M…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim
The prognostic immune nutritional index (PINI) is increasingly recognized for its potential clinical utility. However, multifaceted evaluations of its ability to predict oncological outcomes in colorectal cancer (CRC) and its association with postoperative infectious complications remain limited.
Methods
We analyzed the preoperative PINI in 487 patients with CRC who underwent surgical treatment between 2006 and 2015 to clarify its clinical relevance.
Results
A low preoperative PINI was significantly associated with several clinicopathological factors indicative of disease progression, including advanced pathological T category ( p < 0.001) and lymph node metastasis ( p = 0.001). It was an independent prognostic factor for disease‐free survival (DFS) (hazard ratio [HR]: 1.91; 95% confidence interval [CI]: 1.22–3.00; p = 0.005) and overall survival (OS) (HR: 2.51; 95% CI: 1.50–4.18; p < 0.001). A low preoperative PINI was also an independent risk factor for total infection (odds ratio [OR]: 1.82; 95% CI: 1.11–3.00; p = 0.02), encompassing all postoperative infectious complications. In a subgroup analysis of patients with stage III and high‐risk stage II CRC, a low preoperative PINI was an independent prognostic factor for both DFS (HR: 2.03; 95% CI: 1.24–3.32; p = 0.005) and OS (HR: 3.64; 95% CI: 1.61–8.19; p = 0.002). Additionally, propensity score matching analysis demonstrated that patients with a low preoperative PINI had significantly worse DFS ( p = 0.01) and OS ( p = 0.02).
Conclusion
The preoperative PINI is a valuable biomarker for both perioperative risk assessment and long‐term oncological management in patients with CRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Reparative Medicine, Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences Mie University Graduate School of Medicine Tsu Japan.
- Department of Genomic Medicine Mie University Hospital Tsu Japan.
ORCID-Profile: Shinji Yamashita, Yoshinaga Okugawa, Takahito Kitajima, Masaki Ohi, Yuji Toiyama
Zitieren
APA
Yamashita, S., Okugawa, Y., Imaoka, H., Shimura, T., Kitajima, T., Kawamura, M., Okita, Y., Ohi, M., Kobayashi, M., & Toiyama, Y. (2026). Impact of Low Preoperative Prognostic Immune Nutritional Index on Survival and Postoperative Infectious Complications in Patients With Colorectal Cancer. Annals of Gastroenterological Surgery, 10(1), 154-166. https://doi.org/10.1002/ags3.70084
Vancouver
Yamashita S, Okugawa Y, Imaoka H, Shimura T, Kitajima T, Kawamura M, et al. Impact of Low Preoperative Prognostic Immune Nutritional Index on Survival and Postoperative Infectious Complications in Patients With Colorectal Cancer. Annals of Gastroenterological Surgery. 2026;10(1):154-166. doi:10.1002/ags3.70084
BibTeX
@article{Yamashita2026,
author = {Yamashita, Shinji and Okugawa, Yoshinaga and Imaoka, Hiroki and Shimura, Tadanobu and Kitajima, Takahito and Kawamura, Mikio and Okita, Yoshiki and Ohi, Masaki and Kobayashi, Minako and Toiyama, Yuji},
title = {Impact of Low Preoperative Prognostic Immune Nutritional Index on Survival and Postoperative Infectious Complications in Patients With Colorectal Cancer},
journal = {Annals of Gastroenterological Surgery},
year = {2026},
volume = {10},
number = {1},
pages = {154--166},
doi = {10.1002/ags3.70084}
}
EUVIMED